Near-Infrared Spectroscopic (NIRS) Tissue Oxygen Saturation and the Vascular Occlusion Test in Cardiac Surgery Patients
1 other identifier
observational
13
1 country
1
Brief Summary
Tissue oxygen saturation (StO2) and its recovery during a vascular occlusion test (VOT) will be measured in elective cardiac surgery patients undergoing cardiopulmonary bypass using a non-invasive near infrared spectrometry (NIRS) machine. The purpose of this study is to determine whether changes in VOT measurements occur in patients during cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 23, 2012
CompletedFirst Posted
Study publicly available on registry
October 24, 2012
CompletedOctober 26, 2012
October 1, 2012
October 23, 2012
October 25, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VOT reperfusion slope
Reperfusion slope as measured during vascular occlusion test in units of %/s
Intra-operative (within 12 hours)
Study Arms (1)
VOT on bypass
Eligibility Criteria
Elective cardiac surgery patients undergoing coronary artery bypass and valve surgery using cardiopulmonary bypass.
You may qualify if:
- Adult, elective cardiac surgery patients
- Procedure using cardiopulmonary bypass
You may not qualify if:
- Contraindication to pneumatic cuff inflation
- Pregnant
- Significant peripheral vascular disease of the arms
- Emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
John M Murkin, MD, FRCPC
London Health Sciences Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 23, 2012
First Posted
October 24, 2012
Study Start
February 1, 2011
Study Completion
September 1, 2011
Last Updated
October 26, 2012
Record last verified: 2012-10